Personalised cancer vaccine lowers relapse risk in big trial

A major trial has found that the first personalised cancer vaccine reduced the chance of the disease returning. Researchers say the findings could mark a turning point in treatment, moving tailored medicine closer to everyday use. Further work will be needed before the vaccine becomes widely available to patients.